A Novel Molecular Targeting Compound as K-samII/FGF-R2 Phosphorylation Inhibitor, Ki23057, for Scirrhous Gastric Cancer
Kazunori Nakamura(Osaka City University), Kosei Hirakawa(Osaka City University)
Cited by 70
Related Papers
Hypoxia Stimulates the EMT of Gastric Cancer Cells through Autocrine TGFβ Signaling
|PLoS ONE|2013|98
Efficacy of epidermal growth factor receptor-targeted molecular therapy in anaplastic thyroid cancer cell lines
|British Journal of Cancer|2005|68
A c-Met inhibitor increases the chemosensitivity of cancer stem cells to the irinotecan in gastric carcinoma
|British Journal of Cancer|2013|58
Synergistic antitumor effects of FGFR2 inhibitor with 5‐fluorouracil on scirrhous gastric carcinoma
|International Journal of Cancer|2009|51